BPC-157 & TB-500 & GHK-Cu Blend (70mg)
BPC-157 / TB-500 / GHK-Cu provides a high-purity, laboratory-verified lyophilized multi-peptide blend manufactured under strict quality control standards in the USA. Formulated as an advanced triple-action tissue regeneration complex, each vial combines 10 mg of BPC-157 (Body Protection Compound-157), 10 mg of TB-500 (Thymosin Beta-4 fragment), and 50 mg of GHK-Cu (Copper Tripeptide-1). This synergistic 70 mg total blend is widely utilized in orthopedic, dermatological, and cellular repair research examining angiogenesis, actin sequestration, collagen remodeling, and wound healing cascades.
Key Specifications
Ā Active Compounds: BPC-157 (Pentadecapeptide), TB-500 (Thymosin Beta-4 Fragment), & GHK-Cu (Copper Tripeptide-1)
Ā Blend Concentration: 10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu (70 mg total per vial)
Ā Chemical Formulas: \text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22} (BPC-157) / \text{C}_{212}\text{H}_{350}\text{N}_{56}\text{O}_{78}\text{S} (TB-500) / \text{C}_{14}\text{H}_{24}\text{CuN}_{6}\text{O}_{4} (GHK-Cu)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Synergistic Angiogenesis & Microvascular Repair: Combines BPC-157's VEGFR2 pathway modulation with TB-500's cell migration properties to evaluate accelerated capillary outgrowth and blood vessel formation in damaged tissues.
Ā Extracellular Matrix & Collagen Synthesis: GHK-Cu works in tandem with BPC-157 and TB-500 to stimulate Type I and III collagen expression, dermal fibroblast activation, and glycosaminoglycan production.
Ā Musculoskeletal Tissue Regeneration: Extensively studied in tendon, ligament, muscle, and fascial injury models to measure actin regulation, cell migration to damage sites, and reduced inflammatory scarring.
BPC-157 & TB-500 Blend 20mg
BPC-157 / TB-500 20mg provides a high-purity, laboratory-verified lyophilized peptide blend manufactured under strict quality control standards in the USA. Formulated as a synergistic tissue recovery complex, each vial combines BPC-157 (Body Protection Compound-157, a synthetic pentadecapeptide) with TB-500 (Thymosin Beta-4 synthetic fragment). This dual-action blend is widely utilized in orthopedic, gastrointestinal, and cellular repair research examining accelerated wound healing cascades, microvascular formation, actin regulation, and connective tissue remodeling.
Key Specifications
Ā Active Compounds: BPC-157 (Pentadecapeptide) & TB-500 (Thymosin Beta-4 Fragment)
Ā Chemical Formulas: \text{C}_{62}\text{H}_{98}\text{N}_{16}\text{O}_{22} (BPC-157) / \text{C}_{212}\text{H}_{350}\text{N}_{56}\text{O}_{78}\text{S} (TB-500)
Ā Purity Standard: Exceeds 99% (Third-Party HPLC Verified)
Ā Formulation: Sterile Lyophilized Powder
Ā Origin: Manufactured in USA
Ā Classification: Research Use Only
Primary Research Applications
Ā Angiogenesis & Microvascular Upregulation: Combines BPC-157's VEGFR2 pathway upregulation with TB-500's endothelial cell migration properties to study rapid blood vessel formation in damaged tissues.
Ā Actin Polymerization & Cell Mobility: TB-500 sequestering of G-actin works alongside BPC-157 to examine accelerated cell migration, tendon-to-bone insertion recovery, and fascial repair.
Ā Cytoprotection & Inflammation Modulation: Evaluated in cellular stress models to investigate the downregulation of pro-inflammatory cytokines and stabilization of mucosal and musculoskeletal matrices.